Paxlovid for Long Covid

Research is exploring the potential of extended Paxlovid courses for individuals suffering from long Covid, with some patients reporting significant symptom improvement. However, experiences vary widely, and factors such as dosing and viral reactivation may influence outcomes. The need for further research and subgroup analyses is emphasized to better understand who may benefit from this treatment.